CCantor AASML · ASML

Cantor Fitzgerald Reiterates Overweight on ASML, €2,500 PT

Sep 14, 2026· Analyst: C.J. Muse· 1 min read· Reproduced verbatim
Rating
Buy
Price target
Previous
Implied upside

Cantor Fitzgerald analyst C.J.

Muse reiterated an Overweight rating and €2,500 price target on ASML Holding NV (ASML:NA) (NASDAQ: ASML).

“ASML shares have significantly underperformed front-end peers over the last 1-, 3-, and 5-year timeframes as investors have fretted over peaking litho intensity, worried about the implications of 3D DRAM, and, more recently, concerned about potential negative implications from the MATCH Act.

In turn, ASML’s monopoly-led P/E multiple premium to peers has completely vanished.

Looking ahead, we expect litho intensity to accelerate higher starting in 2HCY27; we do not see 3D DRAM coming into the picture for another decade (in fact, 6F2/4F2 investments have only accelerated both low NA and high NA investments by DRAM makers), and we view risk from the MATCH Act as minimal.

Moreover, layer in our stronger litho unit checks for CY26/27/28, an exciting GM expansion story, and the company’s commitment to real operating leverage, and we believe ASML shares are at an inflection point.

We have raised our EPS estimates across the board based on our latest litho checks and now see stretch-goal EPS +13%/+16%/+18%/+20% vs. consensus for CY26/27/28/29.

As we reflect on an underappreciated margin story, positive estimate revisions, and Capital Markets Day planned for June 2027, we believe shares are ripe for outperformance.

We reiterate our Overweight rating and €2,500 price target, suggesting ~70% upside from current levels. ASML remains a Top Pick.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.